Abemaciclib CDK (cyclin-dependent kinase) inhibitor

Verzenio - LY2385219 - LY2835210 - abemaciclib

Advanced breast cancer (metastatic)

All type of patients:  1 trials  - MONARCH 3

Abemaciclib +nsAI vs nsAI

progression or death (progression free survival PFS) by 46% (fully demonstrated)
See more clinical conditions

HR+ HER2-:  1 trials  - MONARCH 3

Abemaciclib +nsAI vs nsAI

progression or death (progression free survival PFS) by 46% (fully demonstrated)

Lung cancer (metastatic)

All type of patients:  1 trials  - JUNIPER

abemaciclib vs erlotinib

No demonstrated result



- About - Browse pathology | treatment - Site map - Credits Made with in Lyon - Contact us - Privacy policy - Licence Creative Commons